Antidyslipidemia pharmacotherapy in chronic kidney disease: A systematic review and Bayesian network meta-analysis
Pharmaceutics(2023)
摘要
In nondialysis CKD patients, statin-based therapies could significantly and safely reduce all-cause death and major composite cardiovascular events despite the presence of arteriosclerotic cardiovascular disease and LDL-c levels. Aggressive medication regimens, PS and HS, appeared to be more effective, especially in patients with established CAD.
更多查看译文
关键词
antidyslipidemia pharmacotherapy,bayesian network meta-analysis,chronic kidney disease,systematic review
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要